Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine
- 2 January 1993
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 341 (8836) , 63
- https://doi.org/10.1016/0140-6736(93)92546-6
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Genetically variable metabolism of antidepressants and neuroleptic drugs in manPharmacogenetics, 1993
- Evolution of a highly polymorphic human cytochrome P450 gene cluster: CYP2D6Genomics, 1992
- Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoinClinical Pharmacology & Therapeutics, 1992
- Clinical Pharmacokinetics of ClomipramineClinical Pharmacokinetics, 1991
- Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplificationThe Lancet, 1990
- Extremely Rapid Hydroxylation of DebrisoquineTherapeutic Drug Monitoring, 1985
- Plasma levels of chlorimipramine and its demethyl metabolite during treatment of depressionClinical Pharmacology & Therapeutics, 1979